The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of regorafenib plus biweekly TAS-102 for refractory metastatic colorectal cancer (REGTAS): A multicenter single-arm phase II trial.
 
Xiangling Wang
No Relationships to Disclose
 
Zhen Li
No Relationships to Disclose
 
Dan Sha
No Relationships to Disclose
 
Haipeng Ren
No Relationships to Disclose
 
Cuihua Yi
No Relationships to Disclose
 
Shuguang Li
No Relationships to Disclose
 
Peng Wang
No Relationships to Disclose
 
Yunxia Chu
No Relationships to Disclose
 
Jian Wang
No Relationships to Disclose
 
Xiaorong Yang
No Relationships to Disclose
 
Jing Hao
No Relationships to Disclose